Oscar Schwartz, MD
Sleep Medicine · Saint Louis, MONPI 1003807314
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,997 of the $2,600 with a category attached, or 76.8%. 10 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 37.8% of the total. Reporting peaked in 2023 at $1,361 and has fallen 90.0% since, to $136 in 2024.
Across 84 payments — averaging $30.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$983
- Harmony Biosciences LLC$733
- Jazz Pharmaceuticals Inc.$410
- Resmed Corp$206
- Axsome Therapeutics, Inc.$78
- Idorsia Pharmaceuticals US Inc$70
- plus $119 from 4 others
What the payments were for
- Travel & lodging$39315%
- Food & beverage$1,99777%
- Education$2098%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 15 | $983 |
| Harmony Biosciences LLC | 30 | $733 |
| Jazz Pharmaceuticals Inc. | 16 | $410 |
| Resmed Corp | 8 | $206 |
| Axsome Therapeutics, Inc. | 4 | $78 |
| Idorsia Pharmaceuticals US Inc | 4 | $70 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $36 |
| Fisher & Paykel Healthcare Inc | 1 | $20 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,600 in reported general payments places this provider in the 75th percentile of 33 sleep medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 175 | $3,062 |
| Trazodone Hcl | 234 | $2,928 |
| Temazepam | 21 | $1,279 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 76 | $850 |
| Ipratropium Bromide | 24 | $757 |
| Azelastine Hcl | 13 | $606 |
| Quetiapine Fumarate | 20 | $552 |
| Pregabalin | 16 | $450 |
| Ropinirole Hcl | 18 | $309 |
| Clonazepam | 50 | $233 |
| Mirtazapine | 13 | $216 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Saint Louis
- Raman MalhotraSaint Louis$7K
- Rutwik PatelSaint Louis$4K
- Rod Elliott-MullensSaint Louis$2K
- Julie SahrmannSaint Louis$1K
- Annie NguyenSaint Louis$455
- Alvan OmeniSaint Louis$398
- Shalini ParuthiSaint Louis$280
- Venkat Chintapally RaoSaint Louis$228
- Gabriela DebruinSaint Louis$125
- Eric LandsnessSaint Louis$105
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.